You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Dutch informatics firm will use the funds to further develop its cloud-based platform to help customers process large volumes of genomic data.
The partners will work on pilot projects that use novel analytical approaches to explore oncology molecular and imaging data.
Tute will provide its cloud-based informatics and genome analysis platform to support two new NGS testing panels that NSO is developing.
Cavatica is a project of CHOP's Center for Data Driven Discovery in Biomedicine and is part of its commitment to the Precision Medicine Initiative.
Both companies have made their products available on Azure, and Curoverse is collaborating with Microsoft on benchmarking tools for analysis pipelines.
The partners are working to implement the University of Cologne's QuickNGS software on Bluebee's cloud-based platform
Their combined offering will provide customers with a single solution for managing lab operations and performing sequence analysis and mutation identification.
WuXi NextCode will analyze genomes from many tumor types as part of San Antonio's large-scale, community-wide cancer sequencing project.
GenomOncology's software will now support interpretation of ArcherDx mutation-detecting sequencing assays and the products will be marketed together.
A collaborative effort involving four UK universities is attempting to provide communal compute, storage, algorithms, and pipelines for analyzing microbial genomes.
The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.
According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.
NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.
In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.